How do you decide on the timing and urgency of transplant evaluation when a patient recovering from alcohol-associated hepatitis has rapid biochemical improvement (MELD falls into the low teens) but persistent portal-hypertension features and frailty/sarcopenia?

This is a great question, but it needs to be individualized. First: What is the time interval since presentation till MELD drop? Second: What is the patient's age, and what other comorbidities may require attention before or for a transplant evaluation, in particular risks of coronary disease and he...